[go: up one dir, main page]

AU9395998A - Compositions and methods for the treatment of immune related diseases - Google Patents

Compositions and methods for the treatment of immune related diseases

Info

Publication number
AU9395998A
AU9395998A AU93959/98A AU9395998A AU9395998A AU 9395998 A AU9395998 A AU 9395998A AU 93959/98 A AU93959/98 A AU 93959/98A AU 9395998 A AU9395998 A AU 9395998A AU 9395998 A AU9395998 A AU 9395998A
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
related diseases
immune related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU93959/98A
Inventor
Sherman Fong
Audrey Goddard
Austin L. Gurney
Daniel Tumas
William I. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU9395998A publication Critical patent/AU9395998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • G01N33/5758
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU93959/98A 1997-09-17 1998-09-17 Compositions and methods for the treatment of immune related diseases Abandoned AU9395998A (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US5911997P 1997-09-17 1997-09-17
US60059119 1997-09-17
US5926397P 1997-09-18 1997-09-18
US60059263 1997-09-18
US6355097P 1997-10-28 1997-10-28
US60063550 1997-10-28
US6518697P 1997-11-12 1997-11-12
US60066770 1997-11-12
US6636497P 1997-11-21 1997-11-21
US60066364 1997-11-21
US6677097P 1997-11-24 1997-11-24
US60065186 1997-11-24
US8802698P 1998-06-04 1998-06-04
US60088026 1998-06-04
PCT/US1998/019437 WO1999014241A2 (en) 1997-09-17 1998-09-17 Compositions and methods for the treatment of immune related diseases

Publications (1)

Publication Number Publication Date
AU9395998A true AU9395998A (en) 1999-04-05

Family

ID=27568153

Family Applications (1)

Application Number Title Priority Date Filing Date
AU93959/98A Abandoned AU9395998A (en) 1997-09-17 1998-09-17 Compositions and methods for the treatment of immune related diseases

Country Status (2)

Country Link
AU (1) AU9395998A (en)
WO (1) WO1999014241A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019991A1 (en) * 1999-09-15 2001-03-22 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6951924B2 (en) 1997-03-14 2005-10-04 Human Genome Sciences, Inc. Antibodies against secreted protein HTEBYII
US6878806B2 (en) 1997-03-14 2005-04-12 Human Genome Sciences, Inc. Human secreted protein HTEEB42
US7169906B2 (en) 1997-09-17 2007-01-30 Genentech, Inc. PRO211 polypeptides
US20030044839A1 (en) 1997-09-17 2003-03-06 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6974689B1 (en) 1997-09-18 2005-12-13 Genentech, Inc. Nucleic acid encoding PRO211 polypeptides
IL141551A0 (en) * 1998-09-17 2002-03-10 Genentech Inc Compositions and methods for the treatment of immune related diseases
EP1878796A3 (en) * 1999-11-30 2008-01-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6828302B1 (en) 1999-12-08 2004-12-07 Xcyte Therapies, Inc. Therapeutic uses of depsipeptides and congeners thereof
ATE353663T1 (en) 1999-12-08 2007-03-15 Cyclacel Pharmaceuticals Inc USE OF DEPSIPEPTIDES AND THEIR ANALOGUES AS IMMUNOSUPPRESSANTS FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, ALLERGIES AND HYPERPROLIFERATIVE SKIN DISEASES
US20030153015A1 (en) 2000-01-20 2003-08-14 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US20050069878A1 (en) * 2001-06-15 2005-03-31 Henry Yue Proteins associated with cell growth, differentiation, and death
WO2003008541A2 (en) * 2001-07-16 2003-01-30 Eli Lilly And Company Extracellular junctional adhesion molecules
CA2675409A1 (en) * 2001-10-19 2003-05-01 Genentech, Inc. Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
EP1513864A4 (en) * 2002-02-08 2006-04-05 Curagen Corp Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001524814A (en) * 1997-03-14 2001-12-04 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド 28 human secreted proteins
JP2002503955A (en) * 1997-03-21 2002-02-05 ジェネティックス・インスチチュート・インコーポレーテッド Secreted proteins and polynucleotides encoding them

Also Published As

Publication number Publication date
WO1999014241A3 (en) 1999-06-10
WO1999014241A2 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU2212299A (en) Compositions and methods for the treatment of tumor
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
AU9016898A (en) Methods and compositions for treatment of restenosis
AU2821295A (en) Compositions and methods for the treatment of tumors
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU5699396A (en) Compositions for the treatment of skin conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase